Industry

DUBLIN–(BUSINESS WIRE)–The “Global Diabetic Neuropathy Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. Diabetic Neuropathy Pipeline Highlights Report 2022 provides the most up-to-date information on key pipeline products within the global Diabetic Neuropathy market. It covers emerging therapies for Diabetic Neuropathy in active clinical development stages including early and late … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Glycomics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product; Application; End User and Geography” report has been added to ResearchAndMarkets.com’s offering. The glycomics market is expected to grow from US$ 1,340.80 million in 2021 to US$ 3,223.30 million by 2028; it is estimated to grow at a CAGR of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Regenerative Medicine Global Market Opportunities And Strategies To 2031” report has been added to ResearchAndMarkets.com’s offering. This report describes and explains the global regenerative medicine market and covers 2016 to 2021, termed the historic period, and 2021 to 2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Patient Monitoring Devices Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Patient Monitoring Devices Market is projected to reach USD 84.10 billion by 2027 from USD 40.08 billion in 2021, at a CAGR 13.14% during the forecast period. Market Statistics: The report provides market … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Synthetic Biology, Logic Gated Therapies, Rapid Molecular Diagnostics and Peptide Synthesis Platforms” report has been added to ResearchAndMarkets.com’s offering. This report focuses on synthetic biology innovations around low cost gene synthesis and deployment of gene circuits for drug discovery and in therapies. Cell and gene therapies using logic gated circuits, … [Read more…]

InPedILD Phase III trial showed encouraging results for both primary endpoints. Full data were published in the European Respiratory Journal and presented at the European Respiratory Society International Congress in Barcelona, Spain If approved, nintedanib would become the first approved treatment for pediatric patients with fibrosing interstitial lung disease, addressing a high unmet need Findings … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Over-The-Counter (OTC) Veterinary Drugs Market Outlook to 2032” report has been added to ResearchAndMarkets.com’s offering. This report on the Over-The-Counter (OTC) veterinary drugs market offers a global industry analysis for 2017-2021 and an opportunity assessment for 2022-2032. The report consists of a comprehensive assessment of the most important market dynamics. On conducting … [Read more…]

PORTSMOUTH, N.H.–(BUSINESS WIRE)–Epredia, a global leader in precision cancer diagnostics, today announced that its parent company PHC Holdings Corporation [TSE 6523] has acquired anatomical pathology suppliers Microm Microtech France (MMFrance) and Laurypath in a strategic expansion of Epredia’s presence in Europe. MMFrance and Laurypath, both founded in 1987 in Lyon, France, manufacture and supply anatomical … [Read more…]

BOSTON–(BUSINESS WIRE)–Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a poster presentation titled: High Activity of Poziotinib in G778_P780dup HER2 Exon 20 Insertion Mutations in Non-Small Lung Cancer (NSCLC). The poster will be presented at the upcoming European Society for Medical Oncology Congress (ESMO) 2022 that will … [Read more…]

Approval based on TOPAZ-1 Phase III trial results, which showed IMFINZI combination reduced risk of death by 20% vs. chemotherapy alone WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca’s IMFINZI® (durvalumab) has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tract cancer (BTC) in combination with chemotherapy (gemcitabine plus cisplatin). The … [Read more…]